Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2019
  2. Published

    Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

    Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Bang Oturai, A., 2019, In: Multiple Sclerosis Journal. 25, 9, p. 1298-1305 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

    International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, I. C. O. S. C. I. A. I. I. M. S. A. N. O. S. D., 2019, In: The Lancet Neurology. 18, 2, p. 185-197 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis

    Magyari, M. & Sørensen, Per Soelberg, 2019, In: Current Opinion in Neurology. 32, 3, p. 320-326

    Research output: Contribution to journalReviewResearchpeer-review

  5. 2018
  6. Published

    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M. & 10 others, Sørensen, Per Soelberg, Tintoré, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C. & Cohen, J. A., 2018, In: Lancet Neurology. 17, 2, p. 162-173

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Disability in progressive MS is associated with T2 lesion changes

    Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S. & 7 others, Selmaj, K., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Thalheim, C., Wiendl, H. & Zipp, F., 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Early versus later treatment start in multiple sclerosis: a register-based cohort study

    the Danish Multiple Sclerosis Group, T. D. M. S. G., 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

    Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, Per Soelberg, Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 2. E. F. W. G., 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

    Comi, G., Cook, S., Rammohan, K., Sørensen, Per Soelberg, Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 2018, In: Therapeutic Advances in Neurological Disorders. 11, p. 1-11

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K., Rieckmann, P., Comi, G., Dangond, F., Adeniji, A. K. & Vermersch, P., 2018, In: Multiple Sclerosis Journal. 24, 12, p. 1594-1604

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...26 Next

ID: 11025